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1 ABSTRACT 39 
 40 
Background: The early diagnosis of infection or sepsis in burns are important for patient care. 41 
Globally, a large number of burn centres advocate quantitative cultures of wound biopsies for 42 
patient management, since there is assumed to be a direct link between the bioburden of a burn 43 
wound and the risk of microbial invasion. Given the conflicting study findings in this area, a 44 
systematic review was warranted.  45 
Methods: Bibliographic databases were searched with no language restrictions to August 2015. 46 
Study selection, data extraction and risk of bias assessment were performed in duplicate using pre-47 
defined criteria. Substantial heterogeneity precluded quantitative synthesis, and findings were 48 
described narratively, sub-grouped by clinical question. 49 
Results: Twenty six laboratory and/or clinical studies were included. Substantial heterogeneity 50 
hampered comparisons across studies and interpretation of findings. Limited evidence suggests that 51 
(i) more than one quantitative microbiology sample is required to obtain reliable estimates of 52 
bacterial load; (ii) biopsies are more sensitive than swabs in diagnosing or predicting sepsis; (iii) high 53 
bacterial loads may predict worse clinical outcomes, and (iv) both quantitative and semi-quantitative 54 
culture reports need to be interpreted with caution and in the context of other clinical risk factors.   55 
Conclusion: The evidence base for the utility and reliability of quantitative microbiology for 56 
diagnosing or predicting clinical outcomes in burns patients is limited and often poorly reported. 57 
Consequently future research is warranted. 58 
 59 
Keywords: burns, infection, systematic review, quantitative microbiology, biopsies, wound swabs  60 
 61 
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2 BACKGROUND 62 
 63 
Infection is a significant complication for patients who survive an initial burn injury. Although there 64 
are a variety of infection routes which may lead to systemic infection and sepsis in the thermally 65 
injured patient, a key route of infection is via the breached and burnt areas of the skin. Here 66 
infection typically starts as bacterial colonisation (with bacteria contained in a biofilm), with the 67 
source bacteria easily introduced onto this exposed and vulnerable surface via a number of 68 
exogenous and endogenous routes. Colonisation may then progress to systemic infection, where 69 
mortality rates range from 5-15% [1], with the majority of the mortality due to pneumonia (25%), 70 
sepsis (26%), urinary tract infections (22%), and acute burn wound infections (5%) [2].  71 
 72 
The longer the colonisation persists, the greater the likelihood of systemic infection [3]. 73 
Furthermore, it is believed that the risks of bacterial invasion and systemic infection increase in 74 
proportion to the size of the skin breach [1].  Consequently, microbiological assessment of burn 75 
wounds particularly when clinical signs of infection are present, or if the wound is deteriorating, or 76 
has changed in appearance, is important in patient management [4,5], and forms the standard of 77 
care in most burns units. This can be achieved with qualitative (bacterial presence/absence), semi-78 
quantitative (some form of bacterial enumeration conducted), or quantitative (full bacterial count 79 
provided) microbiological methods. In the UK, assessment of burn wounds is generally qualitative 80 
and semi-quantitative, and utilises swab cultures [6]. 81 
 82 
Various authors [7,8] have suggested that qualitative and semi-quantitative methods should be 83 
replaced by fully quantitative bacteriology of biopsies in order to improve patient management. The 84 
use of burn wound biopsies for histological and quantitative assessment of the burn wound 85 
originates from Teplitz et al  [9], who stained and  microscopically investigated tissue  for bacteria, 86 
and provided an absolute measure of bacteria per unit of volume.  Using a rat model, Teplitz et al  [9] 87 
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found that increasing numbers of Pseudomonas aeruginosa on a burn wound were followed by 88 
invasion of the underlying viable tissue, and clinical infection.  89 
 90 
A clinical method for quantitative biopsy in burns patients was first described by Loebl et al [10], and 91 
subsequently modified [11,12].  Consequently, there now exist a variety of quantitative methods, 92 
but no universally accepted ‘gold standard’. These methods differ in a number of ways, such as the 93 
method of sample collection, biopsy collection and processing, and timing of collection.  94 
 95 
The evidence for the utility of quantitative burn wound culture is inconsistent. Some animal and in 96 
vitro studies suggest an association between high bacterial counts and infection [13], delayed wound 97 
healing [14], and poor skin graft take [15]. Some clinical  studies were unable to demonstrate a 98 
relationship between bacterial counts and subsequent sepsis or graft loss [11, 16].  99 
 100 
The use of quantitative culture for the prediction of clinical outcomes is only one possible prognostic 101 
variable. Other prognostic factors could include the more traditionally used clinical factors, such as 102 
heart rate, temperature, and blood pressure [16], or newly developed novel tests such as neutrophil 103 
function [17]. The incremental utility of quantitative culture as a prognostic factor should therefore 104 
ideally be evaluated in the context of other known prognostic factors. Furthermore, any evidence on 105 
the prognostic utility of bacterial count (whether as a single prognostic factor or in conjunction with 106 
others), should ideally be evaluated in the context of the evidence on the accuracy and reliability of 107 
the counts obtained. Given the increased use of quantitative methods in some burns centres, and 108 
the varied and sometimes conflicting evidence base, a comprehensive systematic review of all 109 
existing evidence was  warranted.   110 
 111 
 112 
 113 
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3 METHODS 114 
A protocol detailing the methodology was registered (PROSPERO (CRD42015023903)) and published 115 
[18].  A summary of the methods is described here. 116 
 117 
Bibliographic databases were searched to 3rd August 2015 (MEDLINE, PubMed, Embase, CINAHL, 118 
Cochrane Central Register of Controlled Trials (CENTRAL) and Scopus) using a combination of  index 119 
and text words relating to the population (burns patients) and quantitative burn wound 120 
microbiology. There was no restriction by language, study design or outcome.  A sample search 121 
strategy for MEDLINE is shown (Supplementary Figure S1). ZETOC (British library) and the Science 122 
Citation Index (Web of Science) were searched for conference proceedings.  Abstracts from national 123 
and international burns and microbiology conferences were searched from 2012 onwards. Clinical 124 
trial registries were searched for ongoing trials and relevant articles were citation checked.  125 
 126 
Prospective studies using any method(s) of quantitative burn wound microbiology, in patients of any 127 
age with a burn injury were eligible.  Relevant outcomes included any measures of reliability or 128 
repeatability of a single method for obtaining bacterial counts, measures relating to the agreement 129 
between two or more methods, clinical outcomes (such as sepsis or mortality), and their association 130 
with bacterial counts and resource related outcomes (e.g. length of hospital stay). Animal and in 131 
vitro studies, and studies only examining qualitative or semi-quantitative methods, were excluded.  132 
 133 
Study selection, data extraction and quality (risk of bias) assessment were performed in duplicate by 134 
two independent reviewers using pre-specified criteria and standardised forms. Disagreements were 135 
resolved through discussion or referral to a third reviewer. Data was extracted on study aims and 136 
design, patient characteristics, methods and timings of sample collection and culture, length of 137 
follow-up and outcomes.  138 
 139 
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As the review encompassed a range of study designs with different study aims, it was necessary to 140 
include risk of bias criteria from different tools.  Risk of bias assessment therefore included, where 141 
relevant for individual studies, elements from the ‘COnsensus‐based Standards for the selection of 142 
health Measurement Instruments’ (COSMIN) tool [19] (e.g. were any samples taken in duplicate or 143 
was there >1 independent assessor?); the Quality Assessment of Diagnostic Accuracy Studies (revised 144 
tool) (QUADAS-2) checklist [20] (e.g. were samples for both tests collected at the same time?); and 145 
the Quality in Prognosis Studies (QUIPS) tool [21] (e.g. are important potential confounding factors 146 
appropriately accounted for?). Items from the latter tool were important for assessing the 147 
prognostic validity of a study using bacterial count as a prognostic marker of future clinical outcomes 148 
such as sepsis. Items from the former tools related to the reliability and repeatability of different 149 
methods and any agreement between them. Full details of the quality assessment can be found in 150 
Supplementary Figure S2. 151 
 152 
Synthesis was narrative with main findings (and any statistical significance) tabulated. Studies were 153 
grouped by clinical question, with some studies providing evidence for more than one question. 154 
Heterogeneity in population, sampling and culturing methods and reported outcome metrics 155 
precluded quantitative pooling, however similarities and differences between study findings were 156 
described. Where findings were dichotomised according to a threshold, this was considered when 157 
comparing studies. All findings were considered in the context of any risk of bias concerns, and gaps 158 
in the evidence highlighted where appropriate.  159 
 160 
Formal assessment of publication bias was not possible. Preferred Reporting Items for Systematic 161 
Reviews and Meta-Analyses (PRISMA) reporting guidelines [22] were adhered to, and the study 162 
selection process documented using a PRISMA flow diagram.  163 
 164 
 165 
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4 RESULTS 166 
4.1 Overall summary 167 
Twenty-six studies were included (see Figure 1 for selection procedure). The studies were published 168 
between 1974 and 2013, but mostly conducted in the 1970s and 1980s. Twelve were laboratory 169 
comparisons of bacterial counts obtained from different sampling methods, and 14 incorporated 170 
both laboratory aspects and clinical outcomes.  171 
 172 
4.2 Intra-and inter- observer repeatability of the different methods of obtaining bacterial 173 
counts 174 
Only three small studies (46 patients in total) reported on duplicate sampling using duplicate swab 175 
collection [23], duplicate biopsies [24] and both duplicate swabs and biopsies [25]. All duplicate 176 
samples were processed using the same methods, therefore allowing assessment of reliability. No 177 
studies were identified that reported on inter-observer reliability. Details of sampling methods, main 178 
findings and methodological strengths and weaknesses are detailed in Table 1.  179 
Levine et al [23] collected duplicate swabs to assess the variation in quantitative cultures from 180 
widely spaced areas on wounds of uniform clinical appearance.  Twenty four patients, with large 181 
areas of exposed granulation tissue, were included and had swabs collected from four separate 182 
areas per wound. Assessment of variability showed that 95% of the counts obtained from the four 183 
swabs were ±1.7 logs from the mean count per sample set (95% confidence interval (CI)). Mean 184 
counts are not reported. It is also unclear whether the samples with no bacterial growth were 185 
included or excluded from the analysis as per Steer et al [25].  186 
Volenec et al [24] collected 36 punch biopsies from four burns patients (27 pairs analysed), and 187 
assessed the variability in counts per gram between the duplicate samples.  The 95% CI was ±1.31 188 
log10 counts/g across all the samples.  The results from these two studies suggest that a single 189 
sample may be able to provide a reliable approximation of the number of organisms present, 190 
without the need to collect duplicate samples.  191 
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 Steer et al [25], collected duplicate biopsies and swabs (two of each per patient) from 18 patients. 192 
The authors found that there was a significant correlation between the log total bacterial counts 193 
obtained from two simultaneous biopsies (p<0.002), and from two swabs (p<0.001) collected from 194 
the same patient at the same time only if samples without growth were included. When samples 195 
without growth were excluded from the analysis (since by being negative, they are automatically 196 
concordant),  the correlation between simultaneous biopsies was no longer significant, and only 29% 197 
of biopsies and 50% of swab counts agreed within the same log unit.  The 95% CI ranges for biopsies 198 
and swabs respectively were ±5.4 log10 counts/g, and ±3.6 log10 counts/cm
2.  This wide range may be 199 
due to the variation in sampling area for swabs. The authors conclude that single samples are not 200 
sufficient for measuring bacterial counts, and that one sample type cannot be used to predict the 201 
counts obtained from another sample type.  202 
Comparisons across the three studies are difficult owing to the heterogeneity in terms of the 203 
samples collected (all studies involve different sampling methods and sites), and the populations 204 
studied. Several methodological weaknesses were also noted, especially the inadequate detail 205 
regarding how samples were processed. Whilst all studies provide measures of variation, there is no 206 
indication of reference values or guidance on clinical interpretation. Overall, there is insufficient 207 
evidence to draw conclusions on the reliability of the methods described. 208 
 209 
4.3 Agreement between different methods 210 
Twenty two studies [5,11,12,23,25–42] compared two or more methods of quantification, including 211 
charcoal swabs, biopsies (of a variety of types), and blood cultures. The methods for processing the 212 
samples (where stated) tended to be broadly similar, involving collection and plating onto solid agar 213 
(±quantitative counts) for the swabs, and homogenisation, serial dilution and plating (culture) for 214 
the biopsies, although there was a lack of reporting on the method of biopsy collection, or type of 215 
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biopsy for three studies [34,38,39]. Details of all the studies are shown in Tables 2 (A-D), and are 216 
described in the following text.  217 
4.3.1 Agreement in bacterial counts with different sections from the same biopsy/biopsy site 218 
Four studies investigated bacterial counts obtained from different sections of the same biopsy or 219 
biopsy sites [34,38–40], however there are several methodological weaknesses; only one study [40] 220 
provided detail on biopsy collection and processing method, and all provide only minimal detail on 221 
the patient population (Table 2A). Furthermore, each study investigated bacterial counts from 222 
different samples. In the Barret & Herndon [34] study, biopsies were collected from the eschar and 223 
excised wound bed, whereas in Mitchell et al [38] they were from ‘adjacent sites’.  The studies by 224 
McManus et al [39] and Woolfrey  et al [40] collected a single biopsy that was then split for 225 
processing (transversely  [40]; not stated in [39]). Counts are provided for three of the studies 226 
[34,39,40], but, given the paucity of information on the sampling methodology, it is hard to draw any 227 
conclusions regarding any differences observed between counts, as these appear to either represent 228 
distinct samples [34], or represent variation in sampling from the same/similar site [39,40].  Samples 229 
in Woolfrey et al [40] were analysed separately according to whether the same bacterial isolate was 230 
recovered from both split biopsy samples (paired), or whether the samples were discordant 231 
(unpaired). For 43% of the paired biopsies, the quantitative results were within the same log 232 
increment. Combining the paired and unpaired samples, 21% of the quantitative results were within 233 
the same log increments, 19% differed by ±1 log increment, and 60% differed by ±2 log increments 234 
or more. Although there are no reference ranges to guide interpretation, it appears that there is vast 235 
variation in different segments from the same biopsy specimen.  236 
4.3.2 Agreement in bacterial counts between different processes used on single biopsies 237 
Five studies compare quantitative counts from single biopsies processed using quantitative culture 238 
compared to a range of other methods (Table 2B). These include semi-quantitative culture from the 239 
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biopsy homogenate [26], acridine orange microscopy [27], histology [5], quantitative Gram stain 240 
[28], and absorbent discs [41]. The majority of these studies collected biopsies according to Loebl et 241 
al [10], but there is no detail on biopsy collection for the Pruitt & Foley [5] study, and no details 242 
provided on the processing of the sample for two studies [26,27]. The studies also vary in the skin 243 
preparation before biopsy collection, with three removing topical agents prior to sample collection 244 
[26,27,41], and no details on skin preparation for the other studies. This lack of detail makes it 245 
difficult to compare the robustness of study methodologies.  246 
Three studies reported concordance between methods: this ranged from 96% for quantitative versus 247 
semi-quantitative [26], to 100% for quantitative versus acridine orange microscopy [27], but this 248 
latter result is misleading as this only relates to the culture positive samples, and 35% of the culture 249 
negative samples were positive on microscopy. Woolfrey et al [28] report a moderate positive 250 
association (correlation coefficient of 0.5) between quantitative and Gram stains, and using 251 
regression line analysis, indicate that the presence of 1.1x105 stained microorganisms per slide 252 
preparation corresponds to the recovery of 106 cfu/gram on quantitative culture.  Only a small 253 
proportion of samples (17%) were analysed in Pruitt & Foley [5], and no concordance data reported.  254 
Williams et al [41] also provide no summary concordance data for the bacterial counts obtained 255 
from the biopsies versus absorbent discs, instead reporting  the correlation coefficients between the 256 
methods in terms of the frequency of isolation of the four most common organisms. Overall, the 257 
paucity of studies, and heterogeneity between study methodologies, precludes any conclusions 258 
relating to the best method for processing biopsies for obtaining reliable bacterial counts.  259 
 260 
4.3.3 Comparison of bacterial counts obtained from swabs versus biopsies 261 
Seven studies compared bacterial counts obtained from swabs versus biopsies (Table 2C). Biopsy 262 
types  differed between  studies (1-2 cm excision biopsy [29], punch biopsies of various sizes 263 
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[25,31,33], or skin slit  [32]), or were not stated [23,30]. Only one of the seven studies [25] reported 264 
the swab type, and only three report on the surface area volume that was sampled [23,25,32].  265 
 266 
The studies also differed according to whether or not quantitative counts were performed for both 267 
sample types. Three studies report their main findings as ‘concordance between sampling methods 268 
in terms of positive and negative results’; in these studies quantitative counts were not performed 269 
on the swabs [29,30], or were not performed/reported  for either of the sample types [31]. No 270 
quantitative results were reported, and the studies mention only that ‘similar’ bacteria were present 271 
between the two sample types.  272 
 273 
Vural et al [31] compared biopsies and swabs in terms of the microorganisms that were isolated  274 
(i.e. biopsies collected but quantitative microbiology not performed), and found a ‘moderate 275 
correlation’ between the two methods, with a Kappa index value of 41%. Danilla et al [33], also 276 
found a moderate correlation (Kappa index value of 52%) between biopsies and swabs in terms of 277 
identification of bacterial species present.  Although both studies used similar methods, and 278 
collected similar sized punch biopsies (3 and 5mm), it is hard to know what the relevance (for clinical 279 
practice) of a ‘moderate’ Kappa index is.  280 
 281 
Three studies performed quantitative counts on swabs. Winkler et al [32] compared biopsies to 282 
swabs and other ‘surface measures’. Detailed results are not provided, however there was no 283 
statistically significant correlation between the counts obtained from biopsies and swabs. These 284 
findings contrast with Levine et al [23] who found a ‘good’ positive correlation between counts from 285 
the seven sample pairs that were analysed, and Steer et al [25] who report a statistically significant 286 
correlation between bacterial counts obtained from both methods (p<0.001).  287 
 288 
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4.3.4 Comparison of bacterial counts obtained from swabs versus biopsies versus blood cultures 289 
Six studies report the bacterial counts obtained from different samples collected from the same 290 
patient (Table 2D). There is a lack of detail on sample collection for swabs and/or blood cultures for 291 
five studies [11,35–37,42], and the type of biopsy sample collected is not detailed in Bahar et al [42] 292 
(although the weight of the biopsy is stated).  293 
 294 
There is heterogeneity in both the types of biopsy that were collected (Loebl et al [10] method, or 295 
dermal punches), and the preparation of the skin prior to sampling. Only two of the six studies 296 
[36,37] mention that the sampling was performed aseptically. Without aseptic collection, biopsies 297 
may be positive because of translocation of the bacteria into the sample during sample collection 298 
rather than invasion of bacteria. This also applies to the collection of blood cultures and is a 299 
considerable methodological flaw of these studies.  300 
 301 
Another limitation is the lack of detail on timing of sample collection. Three papers give a specific 302 
time for sample collection in terms of post-burn [12,35,36], e.g. samples collected on the 2nd, 4th and 303 
7th days post burn [12]. The other studies are less clear, e.g. ‘within the second week’ [42], within 48 304 
hours of admission [37], or at the start of a change of dressing [11]. It is also often not clear when 305 
the blood samples were collected in relation to the other samples. Furthermore, definitions of what 306 
constitutes a positive culture are only provided for two studies [35,36]. The overall lack of detail 307 
and/or heterogeneity thus hampers any comparisons of study findings.   308 
 309 
Only four studies report concordance findings. The study by Sjoberg et al [37] is the most robust in 310 
terms of methodology. The study involved the collection (at stated time-points) and comparison of 311 
samples (surface swabs, tissue culture and blood culture), and included the regular disinfection of 312 
the skin surface (with 70% ethyl alcohol) prior to the collection of the dermal punch biopsies and 313 
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blood cultures. The authors found a poor correlation (29%) between swabs and biopsies in terms of 314 
no growth or identical bacterial growth. 315 
 316 
This is in contrast to Bahar et al [42], where there was ‘good’ correlation (but no measure provided) 317 
between swabs and biopsies, Uppal et al [12], where the concordance between the swabs and 318 
biopsies was 95%, and Steer et al [11] where there was no significant difference in counts between 319 
the different sample types. These studies however were methodologically weaker owing to the lack 320 
of reporting or performing of skin asepsis.  321 
 322 
4.3.5 Comparison of bacterial counts obtained from biopsies versus blood cultures 323 
One study [43] (not tabulated) compared bacterial counts from biopsies versus blood cultures. 324 
Samples were collected (biopsies as per Loebl et al [10]) from 38 patients with >20% TBSA on the day 325 
of admission to the hospital, and every third day thereafter. They were processed to obtain 326 
quantitative counts, and positives defined by counts ≥104 orgs/g. In terms of concordance between 327 
the samples, 92% of the biopsies were positive, but only 29% of these positives matched a 328 
simultaneously positive blood culture.  329 
 330 
4.4 Association between quantitative microbiology, other measures and clinical outcomes  331 
Thirteen studies [5,10,11,29–31,34–37,42–44] reported clinical outcomes such as sepsis or mortality 332 
Two additional studies were initially considered but subsequently excluded: Winkler et al [32] 333 
reported three case studies only, and Buchanan et al [26] investigated the impact of microbial 334 
counting methods on the decision for antimicrobial therapy, but did not relate this to outcomes such 335 
as sepsis or mortality.  336 
 337 
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4.4.1 Studies reporting sepsis 338 
Sepsis was assessed in nine [5,10,11,29,34,35,37,43,44] of 13 studies. Definitions of sepsis (where 339 
described) varied across the studies (Table 3), and important threshold values for conditions such as 340 
leucopenia and tachypnoea have been omitted. Furthermore, none of the studies  included a full 341 
definition of sepsis that would satisfy the definitions jointly developed by The American College of 342 
Chest Physicians (ACCP), the American Burn Association (ABA) and the Society of Critical Care 343 
Medicine (SCCM) [45,46], although it must be acknowledged that the majority of the studies predate 344 
these guidelines.  345 
Additionally, positive culture thresholds were not defined for seven studies [5,11,30,31,34,42,44], 346 
and for the remainder, the threshold ranged from 104 to 105 bacteria/gram (Table 4). Patient 347 
populations varied between the studies in terms of the %TBSA.  348 
 349 
4.4.2 Utility of different sample types and quantitative microbiology for predicting sepsis 350 
Thirteen clinical studies investigated the ability of swabs, biopsies and/or blood cultures, and 351 
quantitative microbiology to predict a range of clinical outcomes (Table 4). Of the nine studies 352 
investigating sepsis,  two investigated biopsies only [34,44], two compared biopsies to surface 353 
cultures [10,29], two compared biopsies to blood cultures [5,43], and the remaining three [11,35,37] 354 
used all three methods (biospies, surface cultures, and blood cultures). Barrett & Herndon [34] will 355 
not be mentioned further here since there was no definition of sepsis given.  356 
All studies found that biopsies were more sensitive than swabs and/or blood cultures for diagnosing 357 
infection and predicting the likelihood of sepsis. Sjoberg et al [37] showed that the development of 358 
sepsis was better correlated to quantitative burn tissue biopsy cultures than surface swab cultures 359 
(but commented that the time needed for processing limits its predictive and therapeutic value), and 360 
Tahlan et al [29] found that surface swabs in general fail to accurately predict progressive bacterial 361 
colonisation or incipient burn wound sepsis. Additionally, Loebl et al [10] concluded that positive 362 
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wound biopsies performed better than surface cultures (Rodac plates) in terms of predicting the 363 
development of clinical sepsis. Of 210 patients included in this study, 117 had positive surface 364 
cultures, and 73 of these were also positive from the biopsy samples. From the biopsy samples, 365 
48/73 (66%) of the patients became septic, and of these, 15/48 (31%) died.  False positive results 366 
(i.e. patients who had positive biopsies but did not develop sepsis) were found to have either been 367 
treated with sub-eschar, or systemic antibiotics. No patients with sterile biopsies developed sepsis 368 
unless another source of infection was present. The overall conclusions need to be viewed cautiously 369 
however, as it is unclear how many patients with positive surface cultures died, or how many had 370 
positive biopsies in the absence of sepsis.   371 
Eight studies [5,11,29,35–37,42,43] investigated the role of blood cultures in predicting clinical 372 
outcomes, with three [35,42,43] reporting a poor correlation between positive blood cultures and 373 
subsequent sepsis, two finding a positive correlation [29,36], and three [5,11,37] not providing any 374 
results or conclusions in this regard.    375 
Bharadwaj et al [35] found that 16 patients who died of sepsis in their study cohort (and who had 376 
>108orgs/g in biopsies) had negative blood cultures. Bahar et al [42] found that blood culture 377 
positivity was not significantly different between patients who died and survivors (19% vs 18.8%, 378 
respectively), and Marvin et al [43] found blood cultures to be ‘disappointing’ as a means of 379 
diagnosing septic complications since only 30% of septic patients in their study had positive blood 380 
cultures. They also found a false positive rate of 10% (i.e. positive blood culture, but no simultaneous 381 
clinical signs of sepsis). This is  higher than  previously reported rates of 0.6-6.0% [47], but could be 382 
explained by a commensal being isolated from the blood, and delayed onset of sepsis in the patients 383 
the samples were collected from.  384 
In contrast, two studies [29,36] found positive blood cultures to be associated with poor prognosis in 385 
burns patients (especially if they are positive within 24 hours of burn), and in many cases predicted 386 
impending mortality. The data regarding the sensitivity and specificity of blood cultures for the 387 
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diagnosis of sepsis from these studies have to be interpreted with caution. Many of these studies 388 
only required one positive blood culture for their analyses and as discussed previously their 389 
definitions of clinical sepsis were deeply flawed. The ABA criteria [45,46] define blood stream 390 
infection as a recognised pathogen cultured from two or more blood cultures,  or one positive blood 391 
culture in the presence of sepsis. It is also important to consider the timing of blood culture 392 
collection. For example, blood cultures collected from pyrexial patients/episodes are more likely to 393 
be microbiologically positive than those collected from non-pyrexial patients/episodes.  394 
In terms of quality assessment, all of the above studies have methodological limitations which affect 395 
the validity of the data. These include failure to define thresholds for positive cultures [5,11,34], 396 
small sample sizes (n<25) [29,34], and conclusions made in the absence of robust data analysis 397 
[10,29,35,43].  398 
 399 
4.4.3 Utility of different sample types and quantitative microbiology for predicting mortality and 400 
other clinical outcomes 401 
Three studies [30,36,42] investigated whether there was a correlation between quantitative counts 402 
and mortality alone, with a further seven investigating mortality alongside sepsis (Tables 3 & 4). All 403 
performed counts on different samples, and used different thresholds to define positivity, i.e. any 404 
growth ‘considered positive’ [42], threshold not stated [30], and >105 organisms per gram defined as 405 
positive for counts performed from biopsies [36].  406 
Bahar et al [42] evaluated whether quantitative microbiology could predict the likelihood of 407 
mortality by looking at the association between counts from swabs and biopsies  and mortality for 408 
75 patients. There was no statistically significant difference in counts between those who died and 409 
those who survived; 59 patients died, of whom 48 had bacterial counts greater than 1x105 cfus (units 410 
not stated), compared to 16/16 patients who survived but still had this high level of bacterial 411 
bioburden from the biopsy samples (Table 4). This was consistent with the findings from Pruitt & 412 
Foley [5] who performed quantitative counts on biopsies from 23 patients. There was no statistically 413 
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significant difference between the groups: 15/20 (75%) patients with >105 orgs/gram died (the 414 
remaining five survived), whereas 1/3 pts with counts <105 orgs/g died (the remaining two survived).  415 
Steer et al [11] analysed 69 swab and biopsy pairs from patients with 1-65% TBSA, and also 416 
concluded that there was no statistically significant difference in total bacterial counts 417 
(biopsy/surface) between patients judged as a clinical success or failure, and no variation in counts 418 
according to whether patients underwent excision and grafting or change of dressings. However, the 419 
authors also found a significant negative correlation between quantitative counts from swabs and 420 
%TBSA (p=0.006) (i.e as TBSA increases, the counts decrease). This is in stark contrast to what would 421 
be expected, and what is observed in clinical practice, and therefore suggests some error or serious 422 
methodological flaws in the study.  423 
Two studies [29,37] found that there was a difference in terms of bacterial counts in those with 424 
sepsis compared to those without, and three studies [5,30,36] concluded that high bacterial load in 425 
biopsies increased the risk of sepsis and mortality. Sjoberg et al [37] collected swabs, biopsies, and 426 
blood cultures from 50 burns patients, whilst monitoring them (every 4 hours) for signs of sepsis. 427 
The patients were then split into ‘septic’ (n=21) vs ‘non septic’ (n=29). Overall, bacterial load (from 428 
biopsies) was significantly higher (p<0.05) in patients with signs of septicaemia compared to those 429 
without (Table 4). In terms of mortality, 16 of the 21 septic patients had positive tissue cultures, and 430 
8 of these died. There is however no information regarding possible deaths in the non-septic group.  431 
Additionally,  Bharadwaj et al [36] and Krupp et al [30] found that patients with higher bacterial 432 
counts based on biopsies were more likely to die than those with low counts. In Bharadwaj et al [36], 433 
23 of 50 patients died, with 18 deaths being attributed to infection. All 18 had counts >1x108 434 
organisms per gram.  Of note, the counts for the 27 who survived are not provided. Krupp et al [30] 435 
reported that patients with burn wounds which showed >105 organisms/gram in biopsy tissue 436 
seemed to be ‘more likely’ to die even with additional measures (e.g. aggressive wound care, 437 
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assisted ventilation etc). This finding is however based on only 10/21 patients, and a lack of 438 
information on the remaining patients means the findings should be viewed cautiously.   439 
The majority of studies had some methodological limitations, particularly in terms of reporting 440 
outcomes for all patients (not just those with high counts) and there does not appear to be any 441 
correlation between the findings and how robust the studies were.  442 
 443 
4.4.4 Quantitative counts, depth of invasion, and clinical outcomes (sepsis and mortality) 444 
Only one study [5] looked at the relationship between depth of invasion and clinical outcome. Pruitt 445 
& Foley [5] used histology to grade infection (by depth of invasion) from 1 (burn surface) to 6 (most 446 
severe: microbial penetration into viable tissue beyond depth of original necrosis).  There was a 447 
correlation between death and the histology grade, with grade 6 associated with high mortality. 448 
Furthermore, for 19 patients, two or more successive biopsies had shown evidence of increasing 449 
invasion, and 16 (85%) of these patients died. It is hard to draw meaningful conclusions from these 450 
observations in the absence of full results.  451 
 452 
4.4.5  Impacts of quantitative counts on patient management 453 
Two studies looked at the influence of microbiology results on clinical practice. Pruitt & Foley [5] 454 
reported that biopsy findings prompted therapy alteration in 25 patients (total number of patients 455 
unclear), whereas Buchanan et al [26] compared quantitative (Q) counts vs semi-quantitative (SQ), 456 
and found that bacterial counts changed the clinical practice for just two of 78 patients.  The SQ 457 
method was therefore advocated over performing quantitative counts.   458 
 459 
 460 
 461 
 462 
 463 
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5  DISCUSSION 464 
This systematic review was undertaken to clarify the evidence base around the use of quantitative 465 
microbiology (specifically from biopsy samples) for the management of burns patients. This is the 466 
first systematic review in this area and was warranted owing to the conflicting and varied reports of 467 
the clinical utility of quantitative counts in the literature.  A sensitive search strategy meant that is it 468 
unlikely that any studies would have been missed, and detailed risk of bias assessment of included 469 
studies meant that any findings have been set in the context of the methodological quality of the 470 
primary studies.  471 
Twenty six studies were included, of which twelve investigated clinical outcomes. There was 472 
substantial heterogeneity in terms of patient characteristics (%TBSA, type of burn injury, the time of 473 
presentation post burn), sample collection and processing (e.g. the type of biopsy collected, and 474 
whether skin was aseptically cleaned beforehand), the method for performing the counts, the 475 
analysis, and how the clinical outcomes were defined. This precluded any quantitative synthesis (e.g. 476 
meta-analysis), and hence findings are described narratively, sub-grouped by clinical question.  477 
A key finding from this systematic review is that there is not a gold standard nor universally accepted 478 
method for monitoring a burn wound for bacterial colonisation and infection. Studies using any 479 
method of quantitative microbiology from biopsy samples were eligible for inclusion into the review 480 
resulting in a range of different types of biopsy collected, whilst in six studies [5,23,30,34,38,39] the 481 
authors failed to provide any information regarding the biopsy type. Furthermore, the comparator 482 
samples such as swabs, surface plates or blood cultures also varied between studies in how they 483 
were collected (e.g. the area of the skin swabbed), and how they were processed. The different 484 
methods of processing may be the reason why the critical bacterial concentrations necessary for 485 
burn wound sepsis vary so widely between studies.  Freshwater et al [44] for example have 486 
theorised that the method of tissue homogenisation significantly impacts the critical number due to 487 
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less efficient means of homogenisation yielding less recoverable bacteria from tissue samples. It 488 
remains unclear what the best method is to obtain bacterial counts from a burn wound.  489 
In addition to variation in sample types, for some studies, the samples being investigated were not 490 
collected at the same time per patient, or there was no information provided on when (post-burn 491 
injury) the samples were collected. This is of utmost importance when the bacterial counts are being 492 
compared from different sample types and across different studies.  493 
Limited evidence does suggest that it is not sufficient to base clinical decisions on a single sample, 494 
and that swabs (although a convenient sample type) generally only detect the surface flora, and 495 
therefore do not reflect the invasion of the wound and potential progression to sepsis. In terms of 496 
bacterial density and wound invasion, Winkler et al [32] hypothesised that the discrepancy between 497 
surface swab and biopsy findings were linked to bacterial density (i.e. that when bacterial counts are 498 
<105 organisms/g, deep invasion of wounds is not expected and biopsy results then correlate with 499 
surface techniques). However, high bacterial density does not always lead to invasion, as reported 500 
by McManus et al [39]. It is likely that the depth of invasion (especially involvement of healthy tissue 501 
and vascular involvement) in combination with bacterial density on biopsy will be a more accurate 502 
predictor of sepsis and mortality compared to just bacterial density alone.  503 
Furthermore, it is clear that there are insufficient robust studies to fully investigate the utility of 504 
blood cultures; only one study [43] specifically investigated this, but was methodologically weak 505 
owing to biased selection of patients ( those ‘believed to be a high risk of septic complications’), lack 506 
of statistical testing, and incomplete reporting of results. All other studies investigating blood 507 
cultures differed in time of sample collection, with some collected when a pyrexial spike was present 508 
in the patient [29], at a pre-determined time not associated with clinical condition of the patient 509 
[11,35–37], or at an unknown time (detail not provided) [5,42,43].   510 
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In terms of clinical outcomes, eight of nine studies (investigating sepsis) seem to suggest that 511 
biopsies performed better than swabs (or other comparators) in terms of correlation with sepsis. 512 
However the utility of quantitative analysis of biopsies is still not clear as three of 13 clinical studies 513 
[11,42,44] have also reported no correlation of biopsy results with clinical outcomes. These 514 
conflicting findings may be a result of differences in methodological quality between studies, or 515 
other sources of heterogeneity (e.g. population characteristics).   Methodological flaws (or omissions 516 
in reporting) in the clinical studies include:  the time of sample (biopsy) collection not being stated 517 
(bacterial density and antibiotic resistance has been shown to increase with longer time from burn 518 
[35,37,48,49]), the lack of a common definition of sepsis, and ambiguity surrounding when mortality 519 
is attributed to infection. For infection-attributed deaths, there is no clear definition or explanation 520 
on how this was decided (e.g. in some cases, patients may have died of other non-infection related 521 
cause). All of these factors may affect the robustness of the clinical findings, and these should 522 
therefore be interpreted very cautiously. Furthermore, none of the studies have adjusted their 523 
findings for potential confounding factors (i.e. other factors that might predispose a patient to 524 
adverse clinical outcomes). These include age, burn depth and severity, and inhalation injury, and 525 
may all lead to an inaccurate attribution of adverse clinical outcomes to high bacterial counts.   526 
It may also be that sepsis is not a suitable clinical outcome to use for burns patients. It has been 527 
recognised for many years now that the SIRS and sepsis criteria do not apply well to burns patients 528 
due to their elevated systemic inflammatory response (e.g. a baseline temperature of 38.5ºC, and 529 
persistent tachycardia and tachypnoea). Many burns patients would thus trigger the criteria even 530 
when no infection is present thus making it difficult to detect true sepsis. Recognising this flaw, the 531 
American Burn Association (ABA) has published improved standardised definitions for sepsis and 532 
infection-related diagnoses for the burn population in 2007 [46]. Higher thresholds and some new 533 
criteria were introduced e.g. using temperature 39°C (versus ACCP and SCCM criteria of 38°C), 534 
tachycardia 110bpm (versus 90bpm), thrombocytopenia (3 days after initial resuscitation) and 535 
hyperglycaemia (>0.200mg/dl),  instead of leucocytosis, as markers of infection. It is thus likely that 536 
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these historical papers (by using simple definitions of sepsis) have overestimated the incidence of 537 
true infection in their studied cohort.  538 
A key question to address surrounds the relevance of bacterial counts to clinical outcomes. Out of 539 
the 13 clinical studies, ten [5,10,29–31,34–37,43] found that high bacterial counts were associated 540 
with a poorer prognosis, although the link between high bacterial density and adverse clinical 541 
outcomes is far from clear, as three studies [11,42,44] found no correlation between clinical 542 
outcomes and high bacterial load or density.  543 
This discrepancy in findings may be due to the fact that the relationship between microbial 544 
colonisation and clinical outcomes is much more complicated and cannot be determined merely by 545 
bacterial load.   Host susceptibility has a significant role in determining the result of a bacterial 546 
infection. The same microbes can cause a wide variety of clinical symptoms ranging anywhere from 547 
asymptomatic infection to fatal disease (dependent on endogenous and exogenous host factors such 548 
as genetic makeup and diet or antibiotic use which can alter their microbiota [48]). Ten of the 13 549 
studies investigated the bacterial species present on the burn wound [5,11,29–31,34,36,42–44].   It 550 
is well known that certain species of bacteria (e.g. Pseudomonas aeruginosa and Streptococcus 551 
pyogenes) when present in the wound bed, increase the likelihood of graft failure [49,50] and 552 
additionally have a different propensity for invasiveness. Microbes cause skin graft failure by the 553 
production of plasmin and proteolytic enzymes that dissolve the fibrin scaffold that allows skin grafts 554 
to adhere to the wound bed and it is known that different bacteria have varying levels of efficiency 555 
in producing these enzymes [51].  556 
It appears from the findings that in addition to bacterial density, the type of bacteria, depth of 557 
invasion (especially the invasion into healthy non-burned tissue,) and antibiotic resistance all need to 558 
be taken into account when analysing these biopsies and correlating them to clinical outcomes.  559 
 560 
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6 CONCLUSION  561 
The evidence base on the utility and reliability of quantitative microbiology for diagnosing or 562 
predicting clinical outcomes in burns patients is limited and poorly reported. Although 26 studies 563 
have been conducted, substantial heterogeneity exists across studies in terms of study aims, 564 
population characteristics, sampling and processing methods, methodological quality and outcome 565 
metrics reported. This is further compounded by gaps in reporting of items/data that could indicate 566 
methodological robustness and other key characteristics. Such gaps include omitting to document 567 
the timing of sample collection in relation to injury, interpretation of data with certain results 568 
excluded (e.g. the exclusion of negative samples by a few of the studies leading to a skewed 569 
interpretation of concordance [25]), and poorly defined clinical outcomes including sepsis criteria. 570 
Furthermore, whilst all studies provide measures of variation, there is no indication of reference 571 
values or guidance on clinical interpretation. The substantial heterogeneity and methodological 572 
flaws make comparisons across studies difficult and hamper the interpretation of findings.  573 
Limited evidence suggests that in order to obtain the most reliable bacterial counts (i) more than 574 
one sample is required, ideally from multiple anatomical areas [44] (due to the variability of bacterial 575 
counts from samples even in different segments of the same biopsy specimen); (ii) in terms of 576 
sensitivity, biopsies generally outperform swabs in diagnosis or predicting sepsis but have limited 577 
applicability due to the longer processing time; (iii) high bacterial loads may predict worse clinical 578 
outcomes (than low bacterial loads) but information on counts need to be combined with other 579 
factors such as depth of invasion and invasion into healthy tissue to be relevant; and (iv) both 580 
quantitative and semi-quantitative culture reports need to be interpreted with caution and not in 581 
isolation but alongside clinical findings. 582 
There is a clear need for a robust study to be performed to fully address the question of whether 583 
quantitative microbiology (namely biopsies) are of clinical utility for the management of burns 584 
patients, and furthermore whether there is indeed a direct link between the bioburden of a wound 585 
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and the risk of microbial invasion. This systematic review has shown that there is currently no good 586 
evidence to prompt a change in practice, since, in additional to the methodological flaws and 587 
shortcomings, 77% of the included studies have been performed more than two decades ago, and in 588 
that period burn wound care has undergone significant changes. These include new treatments 589 
(negative pressure dressings and dermal substitutes), as well as improved burn unit set up and 590 
infection control protocols. Indeed, only one study addressed the utility of quantitative microbiology 591 
in making decisions regarding antimicrobial therapy. This represents an important omission, in light 592 
of the increasing levels of antimicrobial resistance, and the relevance of antimicrobial stewardship 593 
[52]. 594 
Similarly the microbiology field has also seen great advances such as the recognition of the role of 595 
biofilms and improved diagnostic techniques such as real time quantitative Polymerase Chain 596 
Reaction (PCR) identification of microbes [53] and metagenomic profiling of bacterial populations. 597 
These changes may mean that the findings from the older studies (where a limited selection of 598 
bacterial isolation media were used) may no longer be applicable to current clinical practice, and 599 
thus newer studies need to be performed.  600 
Several areas however need to be addressed before such studies are performed. Firstly, faster and 601 
more reproducible techniques for the identification and quantification of bacteria need to be in 602 
place. In the absence of a gold standard method, studies need to be undertaken to check and 603 
improve the reliability/reproducibility of the chosen wound sampling method and as mentioned 604 
previously, multiple site sampling needs to be performed instead of single site sampling. Secondly, 605 
even if quantification is successful, it would only prove useful clinically if the results are available 606 
rapidly (in hours rather than days), and thus rapid techniques need to be tested or devised.  In terms 607 
of clinical outcomes, a standardised minimum (or core) set of clinical outcomes needs to be devised 608 
and agreed upon by all stakeholders in advance, in order to allow comparison of trials across 609 
different centres.   610 
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It is hoped that once a carefully designed multi-centre study has been undertaken that the evidence 611 
base on the utility and reliability of quantitative microbiology for diagnosing or predicting clinical 612 
outcomes in burns patients can be clarified.  613 
  614 
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Table 1: Studies reporting on intra- and inter-observer repeatability of the different methods of obtaining bacterial counts 
Study 
Population 
sample & any 
standard 
treatments 
Type of biopsy 
Type of 
swab 
Main finding 
Methodological strengths (+) and 
weaknesses (-) 
Levine et al 
[23]^ 
 
24 patients with 
large areas of 
exposed 
granulation 
tissue. 
 
No detail on 
standard 
treatments 
 
n/a Not stated. 
Swabs (4 per 
patient) 
collected by 
twirling end 
on 1cm
2
 
section of 
the open 
wound for 5 
seconds.  
Four swabs were collected from 41 
wounds and the mean log bacterial 
counts and standard error calculated per 
wound. The mean standard deviation was 
±0.85 logs, and 95% of all results were 
±1.7 logs from the mean per sample set 
(95% CI).  
 
(-) Inadequate detail in terms of the sampling and the 
standard treatments.  
(-) Inadequate detail in terms of the processing of the 
swabs and how the quantitation was performed.  
Volenec et al 
[24] 
 
Four burn 
patients 
(unknown 
aetiology, 40-67% 
TBSA).  
 
Wounds washed 
free of topical 
antimicrobials 
before sampling 
(but no further 
details) 
4 mm punch 
biopsy (exact 
method not 
stated) were 
collected on 
alternate days. 
 
Patients were 
sampled on a 
number of 
occasions (exact 
details not 
given) 
n/a 36 paired samples collected and 27 
analysed (8 pairs excluded as counts too 
low, and one excluded as counts too 
high).  
 
The counts per gram (in log) were 
compared between the samples in terms 
of range and standard deviation (SD). The 
mean range difference was low at 0.67 
log, and mean SD was 0.64 log. 95% of all 
results were ±1.31 logs from the mean. 
(+) Patients were sampled 2-3 times allowing the utility 
of biopsies to be assessed over time.  
(+) Topical antimicrobials removed from surface before 
sampling.  
(-) Only 4 patients included in the study design 
(-) Exact method of biopsy collection not stated 
(-) Timing of sample collection not stated (acute or 
delayed infection) 
(-) No removal of surface flora before sampling the 
wound via biopsy 
(-) 25% of the paired samples excluded from analysis 
 
 
Steer et al 
[25]
$
 
 
Population not 
stated but 18 
patients in total.  
 
Topical 
antimicrobials (if 
visible) wiped 
3mm biopsies 
(punch or 
collected by 
scalpel) 
Alginate 
swabs 
collected 
from area 
adjacent to 
biopsy site.  
 
Results reported in terms of counts per 
gram (biopsies), and per cm
2 
(swabs). 
There was a significant correlation 
between the log total bacterial counts 
obtained from two simultaneous biopsies 
(p<0.02), and two swabs (p<0.001).  
 
(+) Duplicate samples were collected from the same 
patient at the same time. 
(-) No removal of surface flora before sampling the 
wound via biopsy 
(-) Population not stated 
(-) Inconsistent treatment of wounds prior to sampling 
(-) Area of swabbing unclear: 4 cm
2 
for some swabs, and 
Table 1
away with sterile 
water-soaked 
gauze.  
 
 In samples with growth, only 29% of 
biopsies, and 50% of swab counts agreed 
within the same log unit. The biopsy 
correlation was no longer significant.  
 
20 cm
2
 for others. 
 
^ Variation study 
$
 Parallel cultures  
 
TABLE 2A: Studies investigating the agreement between different test methods (different sections of single biopsy) 
Study 
Population 
sample & 
any 
standard 
treatments 
Type of biopsy Methods compared Main finding 
Methodological strengths (+) and 
weaknesses (-) 
Barret & 
Herndon 
[34] 
 
20 
paediatric 
patients 
with 29-39% 
TBSA 
2 biopsies 
collected from 
each patient 
(type of biopsy 
and method 
not stated) 
QM on biopsies 
from eschar and 
excised wound bed  
Compared counts of bacteria with the 
different biopsy segments – the eschars 
contained 10
4
-10
6
 cfu/g, compared to the 
excised wound bed (10
2
-10
4
 cfu/g). Difference 
was statistically significant. 
 
(+) The patients were classified according to whether 
acute or delayed presentation. 
(-) The type of biopsy and method of collection not 
stated 
(-) Little information on processing of the biopsy 
 
Mitchell et 
al [38] 
 
Burns 
patients but 
no further 
details. No 
standard 
treatments 
2 biopsies 
collected using 
‘conventional 
techniques’ 
(exact method 
not stated) 
Various methods 
performed on 
biopsies from 
adjacent sites: 
quantitative culture 
and acridine orange 
staining on one, 
histology on other.    
Agreement between testing methods. Of 54 
paired biopsy samples, 49 were negative by 
all methods. Very little data given in terms of 
quantitative counts.  
(-) The type of biopsy and method of collection not 
stated 
(-) No skin prep before biopsy collection 
(-) Hard to compare methods when they are on 
different biopsies 
 
McManus 
et al [39] 
 
200 burns 
patients  
with mean 
TBSA of 54% 
 
Single biopsy 
collected. 
Exact method 
not stated.  
Biopsy split in half, 
one half for 
quantitative culture, 
the other for 
histology. 
Correlation between methods in terms of 
positive and negative results (where <10
5
 
orgs/g).  Good agreement for negative 
cultures, but poor correlation for positive 
samples.  
(-) The type of biopsy and method of collection not 
stated 
(-) No skin prep before biopsy collection 
Woolfrey 
et al [40] 
56 biopsies, 
but no 
detail on 
number of 
patients. No 
standard 
treatments 
Single biopsy 
collected using 
method 
similar to 
Loebl et al [10] 
Single biopsy split in 
half transversely. 
Both segments 
processed by 
quantitative culture 
Compared the counts between the two 
segments. For the paired isolates, 43% of the 
counts were within the same log increment, 
29% differed by ±1 log increment, and 27% 
differed by ±2 log increments.  
(+) Full details given for biopsy processing 
(+) Skin surface cleansed with an alcohol-soaked 
sponge before sampling 
(-) Patient population not stated. 
 
 
Table 2A
TABLE 2B: Studies investigating the agreement between different test methods (same biopsies processed in different ways) 
Study 
Population 
sample & any 
standard 
treatments 
Type of 
biopsy 
Variables compared Main finding 
Methodological strengths (+) and 
weaknesses (-) 
Buchanan 
et al [26] 
 
Population 
not stated.  
1-2cm 
excision 
biopsy (as 
per Loebl et 
al [10]) 
Single biopsy collected 
and processed using 
quantitative (Q) and 
semi-quantitative (SQ) 
methods 
Methods compared according to concordance and 
Q count category. 96% agreement between the 
two methods.  
(+) Topical agents removed prior to sample 
collection 
(-) Missing methodological details 
Husson et 
al [27] 
 
82 patients 
suffering from 
2
nd
 and 3
rd
 
degree burns 
1-2cm 
excision 
biopsy (as 
per Loebl et 
al [10]) 
Single biopsy collected 
and processed using 
quantitative culture 
and acridine orange 
staining. 
Concordance between processing methods in 
terms of counts and positive/negative (but no 
definitions given). 100% agreement for culture 
positive samples. 35% of culture negative samples 
were positive on microscopy. 
(+) Topical agents removed prior to sample 
collection 
(-) Missing methodological details 
 
Pruitt & 
Foley [5] 
 
65 burn 
patients  
Not stated Single biopsy collected 
and processed using 
quantitative culture 
and histology. 
No clear summary measure. Quantitative counts 
only performed for 23 of 132 biopsies. No 
concordance assessment made.  
 
 
(-) The type of biopsy and method of 
collection not stated 
(-) No skin preparation before biopsy 
collection. 
(-) Positive histology result not defined. 
Woolfrey 
et al [28] 
112 biopsies 
collected but 
number of 
patients not 
stated.  
1-2cm 
excision 
biopsy (as 
per Loebl et 
al [10]) 
 
Single biopsy collected 
and processed using 
quantitative culture 
and quantitative Gram 
stain. 
Correlation coefficients measured between the 
counts obtained by culture and the Gram stain = 
0.5 (mild positive association) 
(+) Gram stains and culture performed from 
the same sample 
(-) No details on the population studied 
(-) No skin prep prior to biopsy 
Williams 
et al [41] 
 
228 samples 
collected from 
‘greater than’ 
50 patients 
with 
TBSA>20% 
0.5 by 2cm 
excision 
biopsy (as 
per Loebl et 
al [10]) 
Single biopsy 
compared to an 
absorbent disc (of the 
same size) collected 
from the same area.  
Correlation coefficients between methods in terms 
of bacteria isolated for the four most common 
organisms. Ranges from 0.66 (Enterococci) to 0.86 
(Pseudomonas aeruginosa). No summary 
concordance data given for the bacterial counts.  
(+) Sample processing details provided  
(+) Counts performed on both sample types  
(-) Skin prep performed before sampling (to 
remove topical agents) but no skin 
asepsis. 
 
 
Table 2B
TABLE 2C: Studies investigating the agreement between different test methods (biopsies and swabs) 
Study 
Population sample 
& any standard 
treatments 
Type of biopsy 
Type of 
swab 
Variables compared Main finding 
Methodological strengths (+) and 
weaknesses (-) 
Krupp et al 
[30] 
 
 
 
21 burns patients 
with 10 to >60% 
TBSA. Patients 
treated daily with 
topical 
antimicrobials.  
Not stated Not stated Correlation 
between the 
methods in terms of 
bacteria recovered. 
No counts done for 
the swabs. 
Some shared bacterial 
species between the 
methods but no 
relevant conclusions 
given in the paper.  
(-) Type of biopsy and swab not stated 
(-) No counts performed on the swabs 
(-) No details on sample processing  
Tahlan et al 
[29] 
 
17 patients with 15-
50% TBSA. Patients 
treated with topical 
and systemic 
antimicrobials. 
 
1-2cm excision 
biopsy (as per 
Loebl et al [10]) 
 
Not stated Correlation 
between the 
methods in terms of 
bacteria recovered. 
No counts done for 
the swabs. 
The majority of samples 
(>85%) had similar 
bacterial species in both 
swabs and biopsies.  
(-) No details on sample processing 
(-) No counts performed on the swabs 
 
Vural et al 
[31] 
 
160 patients. 
Regular treatments 
of burns not stated. 
Topical agents 
removed before 
biopsy.  
5mm full 
thickness punch 
biopsy 
Not stated.  Concordance 
between the 
methods in terms of 
bacteria recovered. 
No quantitative 
microbiology results 
given.  
Classified concordance 
between the methods 
(in terms of bacteria 
recovered) in terms of 
the ‘Kappa index’. 41% 
moderate agreement.  
(+) Removal of topical agents before biopsy 
(-) Missing methodological details 
(-) Hardly any mention of quantitative bacterial 
counts in the paper 
  
Danilla et al 
[33] 
1443 paired samples 
from the Burns unit. 
Skin was surgically 
cleansed before 
sample collection 
3mm punch 
biopsy 
Not stated Concordance 
between the 
methods in terms of 
the bacteria isolated 
and the counts. 
Swabs processed 
semi-quantitatively.  
Concordance classified 
in terms of the Kappa 
Overall score of 52% 
(moderate).  
(+) Large sample size (N=1443) 
(-) No detail on the timing of samples 
 
Winkler et 
al [32] 
12 patients with 2
nd
 
and 3
rd
 degree burns 
of 20-70% TBSA. 
Burns regularly 
treated. 
 
Type not stated 
although 
dimensions 
given (0.5cm 
long and 0.2cm 
thick) 
Not stated 
but collected 
from a 1cm
2
 
area 
Concordance 
between methods 
in terms of counts 
and standard 
deviations.  
Poor and non- 
significant correlation 
between the bacterial 
counts from biopsies 
and swabs.  
(+) Good detail given on the processing of the 
swabs and biopsies. 
(+) Counts performed on swabs 
(-) Small sample size (n=12) 
(-) Many results excluded from the analysis 
Table 2C
  
Levine et al 
[23] 
12 patients with 24 
wounds. Regular 
treatment of burns 
not stated.  
Not stated  Not stated 
but collected 
from a 1cm
2 
area 
Concordance 
between methods 
in terms of 
quantitative counts 
and R2 values 
Good positive 
correlation between log 
biopsy cultures, and log 
swab cultures from the 
7 pairs that could be 
analysed.  
(+) Counts performed on swabs 
(-) Biopsy type not stated.  
(-) Small sample size 
Steer et al 
[25] 
74 patients but no 
further details 
3mm punch or 
scalpel biopsy 
(topical 
antimicrobials 
removed prior 
to collection) 
Alginate 
swabs 
collected 
from a 4 or 
20cm
2 
area 
Correlation 
between methods 
in terms of 
quantitative counts 
and R2 values 
Significant correlation 
between total bacterial 
count obtained by 
biopsy and by surface 
swab (p<0.001). 
(+) Topical antimicrobials removed (if visible) 
(+) Quantitative counts performed on swabs 
(-) Non standardised methods for swab and 
biopsy collection 
(-) No skin asepsis prior to collection 
TABLE 2D: Studies investigating the agreement between different test methods (biopsies, swabs and blood cultures) 
Study 
Population sample 
& any standard 
treatments 
Type of biopsy 
Type of 
swab 
Type of 
blood 
culture 
Variables 
compared 
Main finding 
Methodological strengths (+) and 
weaknesses (-) 
Bahar et al 
[42] 
 
75 burns patients 
with >20% TBSA. 
Regular treatment 
of burns not 
stated. 
 
Collected from 
leading edge of 
wound and 1g in 
weight, but type 
not stated. 
 
Not stated Not stated 
(timing 
and 
condition 
of the 
patient not 
stated) 
% 
agreement 
between the 
methods 
Positivity rates: Swabs 
(100%), biopsies 
(89.3%), blood cultures 
(18.9%). Good 
correlation between 
swabs and biopsies  
 
(+) Swabs and biopsies collected at the same 
time and timing is stated. 
(-) No skin asepsis prior to sample collection 
(-) Sample types and collection methods not 
stated 
(-) No definition for positive cultures  
Bharadwaj 
et al [35] 
 
50 burns patients, 
with burns >30-
50% TBSA. 
Quantitative full 
thickness as per 
Loebl et al [10] 
Not stated Not stated Positivity 
rates 
between the 
methods. 
Positivity rates of 94, 
87.6, and 12% for 
swabs, biopsies, and 
bloods, respectively. 
No statistics or 
interpretation given.  
(+) Timing of sample collection stated 
(-) Insufficient details on the processing 
methods.  
(-) No analysis performed in terms of 
concordance between the methods.  
(-) No skin asepsis prior to sample collection 
 
 
Bharadwaj 
et al [36] 
 
50 burns patients, 
with burns >30-
50% TBSA. 
Quantitative full 
thickness as per 
Loebl et al [10] 
Not stated Not stated Positivity 
rates 
between the 
methods. 
 
87.6% of the biopsies 
were positive. No 
results given for swabs 
or blood cultures.  
 
(+) Skin aseptically cleaned prior to sample 
collection 
(-) Insufficient details on the processing 
methods.  
(-) Missing results for positivity rates of 
swabs and blood cultures. 
  
Sjoberg et 
al [37] 
 
50 burns patients, 
with burns >10% 
TBSA. Patients 
bathed daily in 
antimicrobial 
biocides and 
topical antibiotic 
creams applied.  
8mm dermal 
punch taken 
from sites 
showing signs of 
infection 
Not stated Not stated  Positivity 
rates 
between the 
methods.  
Poor correlation in 
between swabs and 
biopsies (no growth or 
identical bacterial 
growth) of only 29%. 
Poor correlation 
between organisms 
isolated from blood vs 
biopsies 
(+) Skin aseptically cleaned prior to sample 
collection 
(+) Timing of sample collection stated 
(-) Definition of a positive culture not 
defined.  
(-) Indication for the collection of a blood 
culture not stated 
  
Table 2D
Steer et al  
[11] 
 
47 burns patients 
with 1-65% TBSA. 
Regular treatment 
of burns with 
topical biocides 
and antimicrobial 
creams.  
 
3mm punch or 
scalpel biopsy 
(topical 
antimicrobials 
removed prior to 
collection) 
 
Alginate 
swabs 
collected 
from a 4 or 
20cm
2 
area 
Not stated.  Bacterial 
counts 
between the 
method 
types  
 No significant 
difference in counts 
between swabs and 
biopsy samples. No 
links in terms of counts 
to positivity of blood 
cultures.  
(+) Topical antimicrobials removed (if visible) 
(-) No skin asepsis prior to sample collection 
(-) Time of sample collection not stated  
 
 
Uppal et al 
[12] 
 
100 burns patients 
with >30% TBSA. 
Numerous 
samples from 
each. Regular 
treatments of 
burns not stated.  
5mm punch 
biopsy 
Not stated 
but 
collected 
from a 
4cm
2 
area 
5-10mls of 
blood 
collected 
and 
cultured 
using the 
BacTec 
automated 
system.  
Positivity 
rates 
between the 
methods. 
Concordance between 
swab and biopsy (95%). 
Blood cultures and 
biopsies both positive 
on 65 occasions, but 
many cases of 
discordance (biopsy 
positive and blood 
culture negative, and 
vice versa.  
(+) Topical agents were removed from the 
sampling site with saline.  
(+) Timing of sample collection stated 
(+) Methods of sample collection and 
processing stated.  
(-) Indication for the collection of a blood 
culture not stated 
 
 
 
 
 
 
TABLE 3: Clinical outcomes investigated and definitions of sepsis utilised by studies 
Study Aim of study 
Clinical outcomes 
studied 
Sepsis definition 
Bahar et al [42] 
 
To evaluate whether QM can predict 
the likelihood of mortality 
Mortality n/a 
Barret & Herndon 
[34] 
To assess the efficacy of burn wound 
excision on decreasing burn wound 
colonisation 
Burn wound infection, 
graft loss, sepsis 
Not defined  
Bharadwaj et al [35] 
 
To evaluate QM methods in the 
diagnosis of burn wound sepsis 
Sepsis, mortality 3 or more of: disorientation, tachypnoea, hypothermia, hyperpyrexia, 
thrombocytopenia, leucopenia, and paralytic ileus. 
Bharadwaj et al [36] 
 
Not clearly stated Mortality n/a 
Freshwater & Su [44] To examine the relationship between 
QM (biopsies) and sepsis 
 
Sepsis 2 or more of: disorientation, hypothermia (<36.4⁰C), hyperpyrexia (>39.2⁰C), 
thrombocytopenia (<70,000 cells/m
2
), leucopenia (<5,000 cells/m
2
), tachypnea 
(>30 bpm), tachycardia (>140bpm), or paralytic ileus. 
Krupp et al [30] 
 
Not clearly stated,  but to evaluate 
biopsies in predicting chances of 
survival 
Mortality n/a 
Loebl et al [10] 
 
To evaluate biopsies as an adjunct to 
the care of burns patients 
Sepsis, mortality 2 or more of: hyperpyrexia, hypothermia, disorientation, leucopenia, 
thrombocytopenia, tachypnoea, tachycardia, or ileus 
Marvin et al [43] 
 
To evaluate the value of blood 
cultures for the diagnosis of sepsis 
Sepsis, mortality Presence of 3 or more significant alterations in physiologic parameters: 
disorientation, paralytic ileus, hyper/hyper thermia, sinus tachycardia, 
tachypnea, severe refractory hypotension, leukopenia, decreased platelets. 
Pruitt & Foley [5] 
 
To assess the utility of biopsies in 
burn patient management 
Sepsis, mortality No clear definition given but they do mention parameters such as temperature 
alteration, lethargy, disorientation, abdominal distention and ileus. 
Sjoberg et al [37] 
 
To evaluate whether QM is useful in 
predicting the possibility of 
septicaemia 
Sepsis, mortality Based on the following parameters (but did not state how many were required 
to be present for diagnosis): body temp (<36⁰C or >39 ⁰C), blood pressure 
(<90mm Hg or a reduction of 40mm HG or more), pulse rate (above 90 BPM), 
altered mental status.   
Steer et al [11] To examine the relationship between 
clinical outcome and bacterial 
densities 
Use of antimicrobials 
within 72 hours of 
operation or dressing 
Appearance of fever (>38⁰C), rigors, hypotension, or graft loss (>5%) 
Table 3
change, sepsis, and 
graft loss. 
Tahlan et al [29] 
 
No clinical aims stated Sepsis, mortality 3 or more of pyrexia, hypothermia, disorientation, leucopenia, 
thrombocytopenia, tachypnoea, tachycardia. 
Vural et al [31] 
 
No clinical aims stated Length of stay n/a 
 
Table 4: Summary of results of studies that have reported clinical outcomes and their methodological strengths and weaknesses.  
Study 
 
Quantitative 
Microbiology 
(number of 
patients; 
%TBSA) 
Threshold for a 
positive culture 
Main Finding 
Methodological strengths (+) and 
weaknesses (-) 
Conclusions 
Bahar et al [42] 
 
Swabs, biopsies 
and blood 
cultures (75; 
>20%) 
Not defined; any 
growth 
considered 
positive 
 
59/75 patients died. Bacterial counts 
of >1x10
5 
cfu (no units) for 48/59 
(81%), and <1x10
5 
for 9/59. All of the 
16 patients who survived had high 
bacterial counts (>1x10
5 
cfu) 
(+) Large sample size compared to other 
studies 
(-) The timing of sample collection is 
unclear with respect to the burn injury 
(-) Patients followed up until discharge or 
death, but unclear on readmission 
(-) No definition of infection 
No statistically significant 
difference between 
bacterial load and 
positive cultures with 
mortality. 
Barret & 
Herndon [34] 
Biopsies: two 
different 
samples from 
the same 
patient (20; 29-
39%) 
Not defined; any 
growth 
considered 
positive 
 
No patients with counts of less than 
10
5
 orgs/g experienced infection or 
graft loss, whereas patients with 
counts above this had a 50% chance of 
infection.  
 
(+) Patients classified into acute or 
delayed in terms of excision 
(-) Delayed excision group received 
healthcare elsewhere (additional variable 
not explored) 
Burn wounds that yield 
bacterial culture counts 
of more than 10
5
 orgs/g 
should be considered at 
risk for invasive burn 
wound infection.  
 
Bharadwaj et al 
[35] 
 
Swabs, biopsies 
and blood 
cultures (50; 
30-50%) 
≥10
4
orgs/g In patients with sepsis, positivity of 
sample types varied: 62.5%, 82.5% 
and 100% for swabs, biopsies, and 
blood cultures, respectively. 23 
patients died, and all had >10
8
orgs/g 
in biopsies. 16 of these had negative 
blood cultures.  
(+) Timing of sample collected stated. 
(-) No statistics performed 
(-) Poor definition of sepsis 
(-) Different numbers of samples collected 
from the patients 
(-) Unclear what the counts were in the 
patients who did not die.  
 
Full thickness biopsy 
culture and bacterial 
counts were the best 
method for rapid 
diagnosis and assessing 
the progress of burn 
wound infection.  
Bharadwaj et al 
[36] 
 
Quantitative 
biopsy, swab 
and blood 
culture (50; 20-
50%) 
Positive biopsies 
defined as QM 
counts of >10
5
 
orgs/g 
 
23/50 patients died. Deaths attributed 
to infection for 18/23 (78%), and for 
all, the bacterial counts were >1x10
8 
orgs/g 
 
(-) No statistical tests performed 
(-) No information of bacterial counts in 
survivors 
(-) Insufficient methodological details 
(-) Mentioned ‘mortality due to infection’, 
but do not state how this was decided or 
proven 
Quantitative counts 
correlated well with the 
clinical condition of the 
patient 
Table 4
Freshwater & Su 
[44] 
 
Quantitative 
full thickness 
biopsies (18; 
>20%) 
 
Not defined; any 
growth 
considered 
positive 
 
285 biopsies collected from 18 
patients on 87 occasions. Bacteria per 
gram quantified and related to signs 
of sepsis. When bacterial counts were 
>10
8
/g, 11 patients had 2 or more 
signs of sepsis compared to 24 with 
less than 2 signs of sepsis.  
 
(+) Topical agents removed prior to 
sample collection 
(-) Patients treated with silver sulfadiazine 
cream 
(+) Definition of sepsis given 
 
No apparent relationship 
between bacteria per 
gram of biopsy and 
clinical signs of sepsis 
Krupp et al [30] 
 
Swabs and 
biopsies (21; 
10->60%) 
Not defined; any 
growth 
considered 
positive 
 
Burn deaths correlated with bacterial 
density on biopsy: 5/21 patients died. 
All 5 had counts >1x10
5
 bacteria/g. 
5/16 had counts <1x10
5
 and survived. 
(-) Results are incomplete – only 10/21 
patients accounted for 
(-) Correlation is claimed, but no statistical 
tests have been performed 
(-) Small sample size 
Biopsies have a 
diagnostic value for 
monitoring wound 
infection. Patients with 
burn wounds which 
showed >10
5 
orgs/gram 
more likely to die even 
with additional 
measures, though this 
number was too small to 
reach statistical 
significance. 
Loebl et al [10] 
 
Surface cultures 
(not swabs) and 
biopsies (210; 
>20%) 
 
Positive biopsies 
defined as QM 
counts of ≥10
4
 
orgs/g 
 
73 patients had a positive biopsy. Of 
these, 48 became septic (25 did not), 
and 15 of these 48 died (33 survived).  
(-) Counts not performed on the surface 
cultures 
(-) No stats performed to see if the 
relationships are significant  
(-) Unclear how sample population of 210 
(from 270) was chosen  
(-) Unclear when the samples were 
collected 
 
The authors conclude 
that ‘biopsy cultures 
more accurately reflect 
burn wound colonisation 
than surface culture 
techniques’, since a 
greater proportion of the 
biopsy positives 
progressed to sepsis than 
the surface cultures.   
Marvin et al [43] 
 
Blood cultures 
and biopsies 
(38; >20%) 
Positive biopsies 
defined as QM 
counts of ≥10
4
 
orgs/g 
 
35 patients had positive biopsies (≥10
4
 
orgs/g). Sepsis occurred in 27/35 
(71%), but only 11/27 also had 
positive blood cultures. 11/35 patients 
died from infection, but 4/11 had 
negative blood cultures.  
(-) No stats performed to see if the 
relationships are significant  
(-) Result reporting is confusing (see text) 
(-) Blood cultures mostly taken in the 
absence of clinical indications (e.g. a 
pyrexial spike) 
Blood cultures are 
disappointing for 
diagnosing septic 
complications, but a 
combination of QM from 
biopsies and clinical 
evaluation did allow 
early therapeutic 
interventions.  
Pruitt & Foley [5] 
 
Biopsies and 
blood cultures 
(65; not stated) 
 
Not defined; any 
growth 
considered 
positive 
 
65 patients, but QM only performed 
for 23. 20/23  with QM counts >10
5
 
orgs/g (15/20 died). 3/23 with counts 
<10
5
 orgs/g (1/3 died) 
(-) Unclear definition of sepsis 
(-) Samples collected at different times per 
patient, and varying number of samples 
collected per patient 
 
 
The authors conclude 
that ‘the severity of 
infection was related to 
the number of deaths’  
Sjoberg et al [37] 
 
Swabs, biopsies 
and blood 
cultures 
(50; >10%) 
Positive biopsies 
defined as QM 
counts of >10
5
 
orgs/g 
 
Patients split into septic (N=21) and 
non-septic (N=29). Biopsy QM counts 
statistically lower in the non-septic 
group (6x10
8 
bacteria/g) compared to 
the septic group (2x10
11 
bacteria/g; 
p<0.05) 
(-) Unclear definition of sepsis 
(+) Sepsis parameters (e.g. blood 
pressure) recorded every 4 hours 
(-) Three different sample types collected 
at different times per patient 
(-) Limited analysis of the data wrt 
mortality 
 
Significant difference in 
counts from biopsy in 
septic vs non-septic 
patients. Sepsis better 
correlated to biopsy QM 
counts than swabs or 
blood cultures. 
Steer et al [11] Swabs, biopsies 
and blood 
cultures 
(47; 1-65%) 
Not defined; any 
growth 
considered 
positive 
 
A total of 69 swab and biopsy pairs 
analysed. There was a significant 
negative correlation between QM 
count from the swab and %TBSA 
(p=0.006).  
(-) Poor definition of clinical outcomes 
(-) Different number of samples collected 
per patient 
(-) Differential treatment of the wounds in 
terms of antimicrobial dressings.   
(-) Blood cultures not collected from each 
patient.  
No significant difference 
in bacterial counts 
between patients judged 
to be a clinical success or 
clinical failure.   
Tahlan et al [29] 
 
Swabs and 
biopsies and 
blood cultures 
(17; 15-50%) 
Positive biopsies 
defined as QM 
counts of >10
5
 
cfu/g 
 
10/17 patients were not septic but 
had QM counts of 1x10
5 
cfu/g. 7/17 
were septic with counts ≥1x10
8 
cfu/g. 
3/7 died and had counts 7x10
8 
cfu/g. 
(-) Small sample size 
(-) No stats performed 
 
 
There was a difference in 
terms of QM count in 
those with sepsis 
compared to those 
without.  
Vural et al [31] 
 
Swabs and 
biopsies (160; 
<30->50%) 
Not defined; any 
growth 
considered 
positive 
 
Almost half (44%) of the patients 
hospitalised for more than 40 days 
had QM counts of ≥1x10
5
 CFU/g, 
compared to 5% in those hospitalised 
for less than 10 days.  
(-) Bias in findings:  Only 18 patients were 
in hospital for more than 40 days 
compared to 73 in for <10 days 
(-) No stats performed for outcome of 
interest 
(-) Limited clinical outcomes 
(-) Limited QM reported 
QM counts increase with 
length of hospital stay 
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